IBD-SMART™
What is IBD-SMART™?
-
Non-invasive at home stool microbiome test
-
Help diagnose two IBD subtypes, Crohn's disease (CD) and Ulcerative colitis (UC)
-
High sensitivity and specificity: 90% and 76% for CD, 85% and 82% for UC
Unmet Need
-
Conventional diagnosis of IBD requires multiple assessments including clinical evaluation, colonoscopy, radiographical imaging and laboratory tests.
-
Colonoscopy is invasive and uncomfortable to patients.
-
Currently available serological and stool tests lack specificity
-
Delayed diagnosis led to delayed treatment
Features of IBD-SMART™
-
Utilization of specially curated bacterial marker panels
-
Detection by cost-effective multiplex droplet digital PR technology.
-
Risk score generation using validated machine learning model.
-
Able to detect IBD in inactive states.
-
Discriminative IBD from other diseases such as colorectal adenoma, colorectal cancer, irritable bowel syndrome, obesity and cardiovascular disease